Q1. In the last 3 months, how many patients have been initiated* on the following agents for treatment for melanoma?
a. Nivolumab (monotherapy)
b. Nivolumab AND Ipilimumab (combination)
*Patients are considered initiated if they have not been treated in the previous 6 months with any of the drugs that are part of the named regimen.
Q2. In the last 3 months, how many patients have been initiated* on the following agents for treatment for Renal Cell Carcinoma?
a. Nivolumab (monotherapy)
b. Nivolumab + Ipilimumab
c. Nivolumab + Cabozantinib
d. Avelumab + Axitinib
*Patients are considered initiated if they have not been treated in the previous 6 months with any of the drugs that are part of the named regimen.
Q3. In the past 3 months, how many patients have been initiated* on the following agents for treatment for Advanced/Metastatic Oesophageal Cancer:
a. Nivolumab (monotherapy)
b. Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidene (5-Fluorouracil or Capecitabine)
*Patients are considered initiated if they have not been treated in the previous 6 months with any of the drugs that are part of the named regimen.
